AptarGroup (ATR) PT Raised to $148 at BofA Securities May 1, 2026 04:57PM
AptarGroup (ATR) Tops Q1 EPS by 4c ; Offers Guidance May 1, 2026 02:28AM
AptarGroup (ATR) Declares $0.48 Quarterly Dividend; 1.5% Yield Apr 23, 2026 05:00PM
Aptar Digital Health partners with Enable Injections for enFuse companion app Apr 8, 2026 05:00PM
AptarGroup names Gael Touya as CEO, Stephan Tanda to retire Mar 17, 2026 05:00PM


Feb 5, 2026 05:14PM AptarGroup (ATR) Tops Q4 EPS by 2c; offers guidance
Jan 22, 2026 05:02PM AptarGroup (ATR) Declares $0.48 Quarterly Dividend; 1.5% Yield
Jan 13, 2026 05:00PM Aptar nasal delivery devices used in CastleVax covid vaccine trial
Jan 9, 2026 07:58AM KeyBanc Reiterates Overweight Rating on AptarGroup (ATR)
Jan 6, 2026 05:00PM Aptar Digital Health partners with ŌURA to integrate migraine tracking app
Dec 17, 2025 05:00PM Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Dec 1, 2025 05:00PM AptarGroup acquires Brazil-based oral dosing packaging firm Sommaplast
Nov 20, 2025 07:30AM KeyBanc: White House GLP-1 Deals Boost Growth Potential for Key Suppliers
Nov 3, 2025 01:59AM William Blair Downgrades AptarGroup (ATR) to Market Perform
Oct 30, 2025 05:03PM AptarGroup (ATR) Tops Q3 EPS by 5c; offers guidance
Sep 10, 2025 08:18AM KeyBanc on AptarGroup (ATR): 'Investor Day Highlights Pharma Dominance and Visibility into LT Growth Targets'
Sep 8, 2025 05:00PM AptarGroup (ATR) Raises Quarterly Dividend 6.7% to $0.48; 1.4% Yield
Jul 31, 2025 05:20PM AptarGroup (ATR) Tops Q2 EPS by 7c; offers guidance
Jul 15, 2025 05:00PM Aptar Pharma acquires clinical trial manufacturing capabilities from Mod3 Pharma
Jul 10, 2025 05:01PM AptarGroup (ATR) Declares $0.45 Quarterly Dividend; 1.1% Yield
May 1, 2025 05:06PM AptarGroup (ATR) Tops Q1 EPS by 4c; offers outlook
Apr 16, 2025 08:02AM AptarGroup (ATR) Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
Feb 7, 2025 02:13PM AptarGroup (ATR) PT Lowered to $205 at Jefferies
Feb 6, 2025 05:22PM AptarGroup (ATR) Tops Q4 EPS by 21c, guides below street
Jan 6, 2025 04:09PM Raymond James Starts AptarGroup (ATR) at Outperform
Oct 28, 2024 06:56AM AptarGroup (ATR) PT Raised to $185 at Baird
Oct 24, 2024 05:02PM AptarGroup (ATR) Tops Q3 EPS by 7c, provides guidance
Oct 22, 2024 05:00PM AptarGroup (ATR) Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
Oct 14, 2024 03:26AM Jefferies Upgrades AptarGroup (ATR) to Buy
Oct 10, 2024 05:00PM AptarGroup (ATR) Announces $500M Share Buyback Declares Dividend
Oct 7, 2024 06:53AM Baird Reiterates Outperform Rating on AptarGroup (ATR)
Oct 3, 2024 02:59PM AptarGroup (ATR) PT Raised to $174 at BofA Securities
Sep 23, 2024 05:01PM Aptar's (ATR) N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
Jul 25, 2024 05:04PM AptarGroup (ATR) Tops Q2 EPS by 1c, provides guidance
Jul 11, 2024 05:00PM AptarGroup (ATR) Raises Quarterly Dividend 9.8% to $0.45; 1.3% Yield